A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.

Key facts

Study ID

NCT07655934

Run by

Abramson Cancer Center at Penn Medicine

People needed

100

Starts

2026-01-20

Expected to finish

2028-12-01

Last updated by the study team

2026-06-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Adult women (age 18 years or older)
• Able to read English or Spanish
• Newly diagnosed with primary stage 0, I, II, or III breast cancer
• Pathological diagnosis within the previous 60 days
• Scheduled to have surgery with a Penn Medicine surgeon

You may not qualify if…

• Women age less than 18 years
• Women without a new primary breast cancer diagnosis
• Women who are pregnant

Where it is running

• Abamson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.